Company name: | Pharma Foods International Co., Ltd. |
Representative: | Mujo Kim, President |
(Securities code: 2929 Prime Market) | |
Inquiries: | Seiyu Harada, General Manager of Corporate Strategy Department |
(Telephone: +81-75-394-8600) |
Pharma Foods International Co., Ltd. (the "Company") previously announced, in its release dated June 16, 2025, titled "Notice Regarding Construction of a New Plant by Our Consolidated Subsidiary and Execution of a Loan Agreement with Financial Covenants," that its Board of Directors had resolved to approve the construction of a new manufacturing facility by its consolidated subsidiary, Meiji Yakuhin Co., Ltd. ("Meiji Yakuhin"), as well as the execution of a loan agreement with financial covenants to finance the construction.
The Company hereby announces that, as of August 19, 2025, Meiji Yakuhin has executed the loan agreement with financial covenants.
-
Overview of the Loan Agreement with Financial Covenants
(1) Contract Execution Date
August 19, 2025
(2) Commitment Term
From August 22, 2025 to October 31, 2028
(3) Execution of Syndicated
Loan Agreement
Arranger: The Bank of Kyoto, Ltd.
Co-Arrangers: THE SHIGA BANK, Ltd. and The Hokuriku Bank, Ltd.
(4) Principal Amount of Debt
JPY 12.3 Billion
(5) Scheduled Final Repayment
Deadline
October, 2038
(6) Details of collateral
Land and buildings (including the new plant) owned by Meiji Yakuhin
(7) Guarantee
Corporate guarantor - Pharma Foods International Co., Ltd.
- Future Outlook
The loan will be disbursed in stages from August 22, 2025 to October 31, 2028, in accordance with the progress of the new plant construction. The impact on results for the fiscal year ending July 2026 is expected to be minimal. Any future events that may have a material impact on results will be disclosed promptly.